IntegraGen S.A.
ALINT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €2,564 | €4,101 | €4,570 | €6,484 |
| % Growth | -37.5% | -10.3% | -29.5% | – |
| Cost of Goods Sold | €4,025 | €1,861 | €5,051 | €3,787 |
| Gross Profit | -€1,461 | €2,267 | -€481 | €2,697 |
| % Margin | -57% | 55.3% | -10.5% | 41.6% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €93 | €2,797 | €198 | €2,065 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€46 | -€2,199 | €1,854 | €359 |
| Operating Expenses | €46 | €598 | €2,052 | €2,423 |
| Operating Income | -€1,507 | -€397 | -€410 | €274 |
| % Margin | -58.8% | -9.7% | -9% | 4.2% |
| Other Income/Exp. Net | €61 | €196 | €129 | -€183 |
| Pre-Tax Income | -€1,446 | -€201 | -€151 | €91 |
| Tax Expense | -€39 | -€60 | -€36 | -€0 |
| Net Income | -€1,407 | -€140 | -€115 | €91 |
| % Margin | -54.9% | -3.4% | -2.5% | 1.4% |
| EPS | -0.21 | -0.021 | -0.017 | 0.014 |
| % Growth | -904.8% | -22.2% | -223.9% | – |
| EPS Diluted | -0.21 | -0.021 | -0.017 | 0.014 |
| Weighted Avg Shares Out | 6,607 | 6,717 | 6,725 | 6,588 |
| Weighted Avg Shares Out Dil | 6,607 | 6,717 | 6,725 | 6,588 |
| Supplemental Information | – | – | – | – |
| Interest Income | €27 | €55 | €55 | €32 |
| Interest Expense | €1 | €2 | €3 | €4 |
| Depreciation & Amortization | €25 | -€707 | €29 | €97 |
| EBITDA | -€1,419 | -€1,787 | -€120 | €167 |
| % Margin | -55.3% | -43.6% | -2.6% | 2.6% |